In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities

Rubio-Perez, Carlota, Tamborero, David, Schroeder, Michael P., Antolín, Albert A., Deu-Pons, Jordi, Perez-Llamas, Christian, Mestres, Jordi, Gonzalez-Perez, Abel +1 more·2015·Cancer Cell
DOI 10.1016/j.ccell.2015.02.007

Cited by (295)

Items 201–295 of 295

  1. Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer
    Ying Jing, Yi Zhang, Hui Zhu, Ke Zhang, Mei‐Chun Cai, Pengfei Ma, Peiye Shen, Zhenfeng Zhang, Minghui Shao, Jing Wang et al. · 2019 · Oncogene
  2. Lifetime Ultraviolet Radiation Exposure and DNA Methylation in Blood Leukocytes: The Norwegian Women and Cancer Study
    Christian Magnus Page, Vera Djordjilović, Therese Haugdahl Nøst, Reza Ghiasvand, Torkjel Manning Sandanger, Arnoldo Frigessi, Magne Thoresen, Marit Bragelien Veierød · 2020 · Scientific Reports
  3. Methods and resources to access mutation-dependent effects on cancer drug treatment
    Hongcheng Yao, Qian Liang, Xinyi Qian, Junwen Wang, Pak Chung Sham, Mulin Jun Li · 2019 · Briefings in Bioinformatics
  4. Conventional Chemotherapy Versus Targeted Therapy
    Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares · 2021 · Springer eBooks
  5. Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology
    Gabriela Echeverría‐Garcés, María José Ramos-Medina, Rodrigo Vargas, Alejandro Cabrera‐Andrade, Adriana Altamirano-Colina, María Paula Freire, Juliana Montalvo-Guerrero, Sebastián Rivera-Orellana, Paulina Echeverría-Espinoza, Luis A. Quiñones et al. · 2024 · Frontiers in Pharmacology
  6. Advancing precision medicine in silico
    Megan Cully · 2015 · Nature Reviews Drug Discovery
  7. Novel nuclear translocation of inositol polyphosphate 4-phosphatase is associated with cell cycle, proliferation and survival
    Rituparna Chaudhuri, Kritika Khanna, Koundinya Desiraju, BIJAY RANJAN PATTNAIK, Damini Vatsa, Anurag Agrawal, Balaram Ghosh · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  8. vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer
    Javier Perales-Patón, Tomás Di Domenico, Coral Fustero Torre, Elena Piñeiro-Yáñez, Carlos Carretero-Puche, Héctor Tejero, Alfonso Valencia, Gonzalo Goméz-López, Fátima Al‐Shahrour · 2019 · Bioinformatics
  9. In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome
    Elena Piñeiro-Yáñez, María José Jiménez‐Santos, Gonzalo Goméz-López, Fátima Al‐Shahrour · 2019 · Cancers
  10. Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes
    Xiaobao Dong, Dandan Huang, Xianfu Yi, Shijie Zhang, Zhao Wang, Bin Yan, Pak Chung Sham, Kexin Chen, Mulin Jun Li · 2020 · Communications Biology
  11. Mutation Analysis of Colorectal and Gastric Carcinomas Originating from Adenomas: Insights into Genomic Evolution Associated with Malignant Progression
    Sung Hak Lee, Jinseon Yoo, Young Soo Song, Chul‐Hyun Lim, Tae‐Min Kim · 2020 · Cancers
  12. Association of mutation and low expression of the CTCF gene with breast cancer progression
    Salman Akhtar, Naseem Akhter, Mohammad Zeeshan Najm, S. V. S. Deo, N. K. Shukla, Shaia Saleh R. Almalki, Raed Alharbi, Abdulmajeed Abdulghani A. Sindi, Abdulmohsen M. Alruwetei, Abrar Ahmad et al. · 2020 · Saudi Pharmaceutical Journal
  13. Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer
    Víctor Treviño · 2019 · Molecular Genetics & Genomic Medicine
  14. A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows
    Jason N. Rosenbaum, Anna Belinda Berry, Alanna J. Church, Kristy Crooks, Jeffrey Gagan, Dolores H Lopez-Terrada, John D. Pfeifer, Hanna Rennert, Iris Schrijver, Anthony N. Snow et al. · 2021 · Journal of Molecular Diagnostics
  15. Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types
    Abel González-Pérez · 2016 · Genome Medicine
  16. MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selection
    Chen He, Luana Micallef, Ziaurrehman Tanoli, Samuel Kaski A, Tero A. Aittokallio, Giulio Jacucci · 2017 · BMC Bioinformatics
  17. A signal-based method for finding driver modules of breast cancer metastasis to the lung
    Gaibo Yan, Vicky Chen, Xinghua Lu, Songjian Lu · 2017 · Scientific Reports
  18. Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies
    Suanna S. Bruinooge, Shimere Sherwood, Stephen Grubbs, Richard L. Schilsky · 2019 · Journal of Oncology Practice
  19. Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board
    Erica B. Bernhardt, Mary Dickinson Chamberlin, Ivan P. Gorlov, Francine Blumental De Abreu, Katarzyna J. Bloch, Jason D. Peterson, Gregory J. Tsongalis, Keisuke Shirai, Konstantin H. Dragnev, Todd W. Miller et al. · 2020 · Practical Laboratory Medicine
  20. Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer
    Vanesa Gregorc, Luca Mazzarella, Chiara Lazzari, Paolo Graziano, Paolo Giovanni Vigneri, Carlo Genova, Luca Toschi, Gennaro Ciliberto, Laura Bonanno, Angelo Delmonte et al. · 2021 · Clinical Lung Cancer
  21. Exploring the OncoGenomic Landscape of cancer
    Lídia Mateo, Oriol Guitart-Pla, Miquel Duran‐Frigola, Patrick Aloy · 2018 · Genome Medicine
  22. A Primer for Access to Repositories of Cancer-Related Genomic Big Data
    John Torcivia-Rodriguez, Hayley Dingerdissen, Ting-Chia Chang, Raja Mazumder · 2018 · Methods in molecular biology
  23. Genome architecture and totipotency: An intertwined relation during early embryonic development
    Teresa Olbrich, Sergio Ruiz · 2022 · BioEssays
  24. The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients
    Moon Nyeo Park · 2023 · International Journal of Molecular Sciences
  25. Seek and Destroy: Relating Cancer Drivers to Therapies
    Emmanuel Martínez-Ledesma, John de Groot, Roel G.W. Verhaak · 2015 · Cancer Cell
  26. Identification and ranking of recurrent neo-epitopes in cancer
    Eric Blanc, Manuel Holtgrewe, Arunraj Dhamodaran, Clemens Messerschmidt, Gerald Willimsky, Thomas J. F. Blankenstein, Dieter Beule · 2019 · BMC Medical Genomics
  27. A PanorOmic view of personal cancer genomes
    Lídia Mateo, Oriol Guitart-Pla, Carles Pons, Miquel Duran‐Frigola, Roberto Mosca, Patrick Aloy · 2017 · Nucleic Acids Research
  28. Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA
    Jianxia Chen, Jun Chen, Fusheng He, Yiqiong Huang, Shan Lu, Haibo Fan, Mingbang Wang, Ruihuan Xu · 2019 · Genetic Testing and Molecular Biomarkers
  29. C3 : Consensus Cancer Driver Gene Caller
    Chenyu Zhu, Chi Zhou, Yun-Qin Chen, Aizong Shen, Zong-Ming Guo, Zhaoyi Yang, Xiangyun Ye, Shen Qu, Jia Wei, Qi Liu · 2019 · Genomics Proteomics & Bioinformatics
  30. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich
    Francesco Iorio, Luz Garcia-Alonso, Jonathan S. Brammeld, Iñigo Martincorena, David R. Willé, Ultan McDermott, Julio Sáez-Rodríguez · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Rational design of cancer gene panels with OncoPaD
    Carlota Rubio-Pérez, Jordi Deu-Pons, David Tamborero, Núria López-Bigas, Abel González-Pérez · 2016 · Genome Medicine
  32. Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing
    Qi Li, Qifan Zhang, Jinzhang Chen, Mengya Zang, Xiaoyun Hu, Rong Li, Jinlin Hou, Jie Zhou · 2022 · Journal of Gastrointestinal Oncology
  33. Clonality and heterogeneity of metachronous colorectal cancer
    Jiabo Di, Hong Yang, Zaozao Wang, Jie Yang, Pin Gao, Beihai Jiang, Xiangqian Su · 2018 · Molecular Carcinogenesis
  34. Alleanza Contro il Cancro: The Accreditation System of the Excellence Network of Italian Cancer Centers in the Precision Medicine Era
    Fabio Palombo, Paolo De Paoli, Ruggero D. Maria · 2015 · Tumori Journal
  35. Computational Prediction of Genetic Drivers in Cancer
    Alice B. S. Nono Djotsa, Ken Chen, Xiaoming Liu · 2016 · Encyclopedia of Life Sciences
  36. ICBS and ECBS Chemical Biology Meeting 2015 - Let Them Come to Berlin!
    Toru Komatsu, Satpal Virdee · 2016 · ACS Chemical Biology
  37. A semi-supervised weighted SPCA- and convolution KAN-based model for drug response prediction
    Rui Miao, Bing-Jie Zhong, Xin-Yue Mei, Xin Luna Dong, Yang-Dong Ou, Yong Liang, Haoyang Yu, Ying Wang, Zi-Han Dong · 2025 · Frontiers in Genetics
  38. Quantifying local malignant adaptation in tissue‐specific evolutionary trajectories by harnessing cancer’s repeatability at the genetic level
    Natsuki Tokutomi, Caroline Moyret‐Lalle, Alain Puisieux, Sumio Sugano, Pierre Martinez · 2019 · Evolutionary Applications
  39. Altered oncomodules underlie chromatin regulatory factors driver mutations
    Joan Frigola, Ane Iturbide, Núria López-Bigas, Sandra Peiró, Abel González-Pérez · 2016 · Oncotarget
  40. Personalized Cancer Treatment and Patient Stratification Using Massive Parallel Sequencing (MPS) and Other OMICs Data
    Mark Abramovitz, Casey B. Williams, Pradip K. De, Nandini Dey, Scooter Willis, Brandon Michael Young, Eleni Andreopoulou, W. Fraser Symmans, Jason Keith Sicklick, Razelle Kurzrock et al. · 2018 · Springer eBooks
  41. Novel Target Discovery of Existing Therapies: Path to Personalized Cancer Therapy
    Dimitris Bertsimas, Ying Daisy Zhuo · 2020 · INFORMS Journal on Optimization
  42. Extreme value theory as a framework for understanding mutation frequency distribution in cancer genomes
    Natsuki Tokutomi, Kenta Nakai, Sumio Sugano · 2021 · PLoS ONE
  43. Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer
    Simona Coco, Silvia Bonfiglio, Davide Cittaro, Irene Vanni, Marco Mora, Carlo Genova, Maria Giovanna Dal Bello, Simona Boccardo, Angela Alama, Erika Rijavec et al. · 2019 · Cancers
  44. Cancer Genomics: Opportunities for Medicinal Chemistry?
    Lirong Wang, Xiang‐Qun Xie · 2016 · Future Medicinal Chemistry
  45. Characterizing and comparing missense variants in monogenic disease and in cancer
    Yizhou Yin, John Moult · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Genetic variation in human drug-related genes
    Charlotta Schärfe, Roman Tremmel, Matthias Georg Schwab, Oliver Kohlbacher, Debora S. Marks · 2017 · arXiv (Cornell University)
  47. Decoding Lung Cancer Radiogenomics: A Custom Clustering/Classification Methodology to Simultaneously Identify Important Imaging Features and Relevant Genes
    Destie Provenzano, John P. Lichtenberger, Sharad Goyal, Yuan James Rao · 2025 · Applied Sciences
  48. Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies
    Gabriela Echeverría‐Garcés, María José Ramos-Medina, Ariana González, Rodrigo Vargas, Alejandro Cabrera‐Andrade, Isaac Armendáriz‐Castillo, Jennyfer M. Garcí­a-Cárdenas, David Ramírez-Sánchez, Adriana Altamirano-Colina, Paulina Echeverría-Espinoza et al. · 2024 · Heliyon
  49. Synergistic suppression of cell growth: Phenmiazine derivatives targeting p53 and MDM2 unveiled through hybrid computational method
    Srinivasan M, Y Ismail, Irfan Navabshan, Mohammed Zaidh S · 2025 · Computational Biology and Chemistry
  50. ECBS & ICBS 2015 Joint Meeting: Bringing Chemistry to Life
    Daniel Varón Silva · 2015 · ChemBioChem
  51. Going beyond genetics to discover cancer targets
    Gabriel J. Sandoval, William C. Hahn · 2017 · Genome biology
  52. Comutation and exclusion analysis in human tumors: A tool for cancer biology studies and for rational selection of multitargeted therapeutic approaches
    Soledad Ochoa, Elizabeth Martínez‐Pérez, Diego Javier Zea, Miguel Ángel Molina‐Vila, Cristina Marino‐Buslje · 2019 · Human Mutation
  53. Methods in Computational Biology
    Ross P. Carlson, Herbert M. Sauro · 2019 · MDPI eBooks
  54. PANACEA: network-based methods for pharmacotherapy prioritization in personalized oncology
    Ege Ülgen, Ozan Özışık, Osman Uğur Sezerman · 2023 · Bioinformatics
  55. Personalized Cancer Therapy Prioritization Based on Driver Alteration Co-occurrence Patterns
    Lídia Mateo, Miquel Duran‐Frigola, Albert Gris‐Oliver, Marta Palafox, Maurizio Scaltriti, Pedram Razavi, Sarat Chandarlapaty, Joaquı́n Arribas, Meritxell Bellet, Violeta Serra et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Integrating gene mutation spectra from tumors and the general population with gene expression topological networks to identify novel cancer driver genes
    Dan He, Ling Li, Zhiya Lu, Shaoying Li, Tianjun Lan, Feiyi Liu, Huasong Zhang, Bingxi Lei, D.N. Cooper, Huiying Zhao · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Vehicles for Delivery of Therapeutic Agent for Cancer Therapy
    Ramakant Joshi, Rajendra Chauhan, Wasim Akram, Pawan Kushwah, Hemant Mourya, Navneet Garud · 2023 · Biological and medical physics, biomedical engineering
  58. Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints after Treatment of Cell Lines with Demethylation
    Manama El Baroudi, Caterina Cinti, Enrico Capobianco · 2016 · Cancer Informatics
  59. From big biological data to big discovery: The past decade and the future
    Xue-Gong Zhang, Rui Jiang, Xiao-Wo Wang, Jin Gu, Ting Chen · 2016 · Chinese Science Bulletin (Chinese Version)
  60. Omics: A Holistic Approach in Cancer Treatment
    Madhumati Bora, Pratibha Parihar · 2018 · Springer eBooks
  61. In-silico approach in risk assessment of nutraceutical properties
    S. Nushusna, Y. H., Hamzah M.S. · 2020 · Food Research
  62. Catharanthus Roseus: A Source of Anticancer Phytomedicines
    Neha Sharma, Indranil Singh, Rohit Sam Ajee, Shuchi Kaushik · 2022 · Compendium of plant genomes
  63. Prognostic Pathways Guide Drug Indications in Pan-Cancers
    Fanlin Meng, Kenan Zhang, Changlin Yang, Ke Zhang, Quan Xu, Ruifang Ren, Yiming Zhou, Yimin Sun, Yan Peng, Yanze Li et al. · 2022 · Frontiers in Oncology
  64. A Novel Bayesian Framework Infers Driver Activation States and Reveals Pathway-Oriented Molecular Subtypes in Head and Neck Cancer
    Zheng­ping Liu, Chunhui Cai, Xiaojun Ma, Jinling Liu, Lujia Chen, Vivian Wai Yan Lui, Gregory F. Cooper, Xinghua Lu · 2022 · Cancers
  65. Inference of epigenetic subnetworks by Bayesian regression with the incorporation of prior information
    Anqi Jing, Jie Han · 2022 · Scientific Reports
  66. Toxicological Profile of Nutraceutical Supplements
    Sumel Ashique, Shubneesh Kumar, Mohd Rihan, Ashish Kumar Garg · 2024 · Springer eBooks
  67. Insider information: Testing cancer drug sensitivity for personalized therapy
    Jing Wang, Qiang Wei, Jixing Ye, Sahitya K. Denduluri, Xin Wang, Maryam K. Mohammed, Hue H. Luu, Rex C. Haydon, Tong‐Chuan He · 2015 · Genes & Diseases
  68. Polypharmacology in Predicting Drug Toxicity: Drug Promiscuity
    Zhiguo Wang, Baofeng Yang · 2022 · Springer eBooks
  69. A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
    Marco Ranzani, Kristel Kemper, Magali Michaut, Oscar Krijgsman, Nanne Aben, Vivek Iyer, Kim Wong, Theodoros I. Roumeliotis, Martin Del Castillo Velasco‐Herrera, Jérémie Nsengimana et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  70. IMPROVING PRECISION IN THERAPIES FOR HEMATOLOGICAL MALIGNANCIES
    Muntasir Mamun Majumder · 2018 · Työväentutkimus Vuosikirja
  71. Guiding Cancer Therapy: Evidence-driven Reporting of Genomic Data
    Júlia Perera‐Bel · 2018
  72. Biomedical data integration in cancer genomics
    Riku Louhimo · 2015 · Työväentutkimus Vuosikirja
  73. METHOD Open Access
    Lasse Maretty, Jonas A. Sibbesen, Anders Krogh · 2014
  74. Whole-exome sequencing of plasma cell-free DNA portrays the somatic mutation landscape of refractory metastatic colorectal cancer and enables the discovery of mutated KDR /VEGFR2 receptors as modulators of anti-angiogenic therapies
    Rodrigo Almeida Toledo, Elena Garralda, Maria Mitsi, Tirso Pons, Jorge Monsech, Estela Vega, Álvaro Otero, Maria Isabel Albarran, Natalia Baños, Yolanda Durán et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Identification and Ranking of Recurrent Neo-Epitopes in Cancer
    Eric Blanc, Manuel Holtgrewe, Arunraj Dhamodaran, Clemens Messerschmidt, Gerald Willimsky, Thomas J. F. Blankenstein, Dieter Beule · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Quantifying local malignant adaptation in tissue-specific evolutionary trajectories by harnessing cancer’s repeatability at the genetic level
    Natsuki Tokutomi, Caroline Moyret‐Lalle, Alain Puisieux, Sumio Sugano, Pierre Martinez · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Beyond Synthetic Lethality: Charting the Landscape of Clinically Relevant Genetic Interactions in Cancer
    Assaf Magen, Avinash Das, Joo Sang Lee, Mahfuza Sharmin, Alexander Lugo, Jorge Silvio Gutkind, Alejandro A. Schäffer, Eytan Ruppin, Sridhar S. Hannenhalli · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Quality assessment of effectiveness evaluations
    Mark Rodgers, Miqdad Asaria, Scott E. Walker, Dean McMillan, Mike P. Lucock, Melissa Harden, S Palmer, Alison J. Eastwood · 2012
  79. Application of DNA- and RNA-based sequencing techniques to tumour tissue samples in the clinical laboratory
    Matthew Beauregard Smith, Oluwatosin Taiwo · 2020 · Diagnostic histopathology
  80. Tumour mutations in long noncoding RNAs enhance cell fitness
    Roberta Esposito, Andrés Lanzós, Taisia Polidori, Hugo Guillen-Ramirez, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Isabel Büchi, Lusine Hovhannisyan, Finn McCluggage et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Cancer Precision Drug Discovery Using Big Data and Artificial Intelligence Technologies
    Bichandarkoil Jayaram Pratima, N. Nalini · 2022 · Advances in computational intelligence and robotics book series
  82. Faculty Opinions recommendation of In silico learning of tumor evolution through mutational time series.
    Sutirtha Chakraborty · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  83. Tumour mutations in long noncoding RNAs enhance cell fitness
    Roberta Esposito, Andrés Lanzós, Taisia Polidori, Hugo Guillen-Ramirez, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Isabel Büchi, Lusine Hovhannisyan, Finn McCluggage et al. · 2022 · Research Square
  84. Lack of detectable neoantigen depletion in treatment-naïve cancers
    Maarten Slagter, Lorenzo F. Fanchi, Marit M. van Buuren, Arno Velds, Gergana Bounova, Lodewyk F.A. Wessels, Ton N. Schumacher · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. DyGS: A Dynamic Gene Searching Algorithm for Cancer Detection
    Jenica Wang, Xue Gong · 2018 · Journal of Emerging Investigators
  86. Cancer Precision Drug Discovery Using Big Data and Artificial Intelligence Technologies
    Bichandarkoil Jayaram Pratima, N. Nalini · 2023 · IGI Global eBooks
  87. Future of Nanotechnology-Based Drug Discovery
    Laksiri Weerasinghe, Imalka Munaweera, Senuri Kumarage · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  88. Application of DNA- and RNA-based sequencing techniques to tumour tissue samples in the clinical laboratory
    Lisa James, Nicola Chadderton, Alice Fair, Magdalena Nowak, Philippe Tanière · 2024 · Diagnostic histopathology
  89. Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategies
    Samantha Espinoza-Ferrao, Gabriela Echeverría‐Garcés, Sebastián Rivera-Orellana, José Bueno‐Miño, Emilia Castellanos-Molina, Melanie Benítez-Núñez, Andrés López‐Cortés · 2025 · Frontiers in Pharmacology
  90. Enhancing the Prognostic Precision of Unsupervised Lung Cancer Subtyping Using a Network-Assisted Data Mining of Early Mutated Driver Genes
    Sujiraporn Pakchuen, Teeraphan Laomettachit · 2025 · International Conference on Bioinformatics and Computational Biology (ICBCB)
  91. Leveraging transposon traps to isolate cell cycle-specific reporter cells
    Yamato Kasahara, Sakura Tamamura, Tomo Kondo, Miho Ohsugi, Kentaro Semba, Shinya Watanabe, Kosuke Ishikawa · 2026 · Heliyon
  92. Extrachromosomal circular DNA: a potential clinical therapeutic target in malignant tumors
    Hao Zhang, Enqing Zhuo, Li Meng, Junxiao Feng, Xingjuan Shi, Xiaoou Sun · 2026 · Cellular & Molecular Biology Letters
  93. Rôle de Xist dans l’homéostasie de l’épithélium mammaire et l’initiation tumorale
    Mary-Loup Picod-Chedotel · 2021
  94. Tumor Lineage–Specific Disparities in Access to Genome-Matched Therapies Among Adolescents and Young Adults in Japan: A Nationwide Genomic Profiling Study
    Naomi Hayashi, Naoki Miyazaki, Ippei Fukada, Masumi Yamazaki, Naoki Fukuda, Arisa Ueki, Akemi Kataoka, Toshimi Takano, Masayuki Watanabe, Seiichi Mori et al. · 2026 · JCO oncology advances.
  95. Bioinformatics for Precision Medicine Analysis to Medical Leeches Using Artificial Intelligence
    Zahraa Ahmad Hussein, Jalila Fayadh Sajit, Wael Ismail Salman · 2026 · Lecture notes in networks and systems